SCHEMBL3372885

SCHEMBL3372885

Fc1cc(F)c(CN2CCC(F)CC2)c(-c2cccs2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
DRD4 P21917 6/20 0.36
DRD2 P14416 4/20 0.36
HTR2A P28223 2/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
DRD5 P21918 1/20 0.35
HTR7 P34969 2/20 0.35
HTT P42858 1/20 0.35
DRD3 P35462 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR1A P08908 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ABL1 P00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374256 0.72 CXCR3 (0.42) KDM4EDRD4DRD2HTR2ALMNA
SCHEMBL3344984 0.67 NPC1 (0.49) KDM4EDRD4SMN1; SMN2DRD5HTR7
SCHEMBL13375733 0.64 ALDH1A1 (0.39) KDM4EPOLBSMN1; SMN2
SCHEMBL3374752 0.63 DRD2 (0.38) KDM4EDRD4DRD2LMNAPOLB
SCHEMBL4207045 0.63 MAPT (0.47) KDM4ELMNASMN1; SMN2MEN1KMT2A
SCHEMBL6205484 0.63 TNFRSF1A (0.54) KDM4ELMNASMN1; SMN2HTTMEN1
SCHEMBL13374367 0.62 MGAT2 (0.39) KDM4ESMN1; SMN2
SCHEMBL2782222 0.62 NPC1 (0.46) KDM4ESMN1; SMN2MEN1KMT2ANPC1
SCHEMBL27965042 0.61 MAPT (0.49) KDM4ELMNASMN1; SMN2HTTMEN1
SCHEMBL31448683 0.61 CYP2A13 (0.69) KDM4ELMNAPOLBHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010045006-A1 METHYLENE AMINES OF THIENO [2,3-D] PYRIMIDINE AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2010-04-22 WO disclosed